Healthy Inc > Products > Calcium Acetate Tablets

Calcium Acetate Tablets

Healthy Inc is a specialized global supplier and exporter of advanced nephrology, internal medicine, and targeted mineral-metabolism therapeutics. We provide ultra-high-purity, kinetically optimized Calcium Acetate Tablets (667 mg), manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This “Phosphate Binder & CKD Specialist” is a massive-volume, highly strategic export to dialysis centers, nephrology hospitals, and government health ministries, serving as the globally mandated intervention for Hyperphosphatemia in End-Stage Renal Disease (ESRD).

Product Overview

This formulation operates as a biochemical “Scavenger” within the digestive tract. In patients with failing kidneys, phosphorus cannot be excreted, leading to dangerous levels in the blood. Calcium Acetate is engineered to physically intercept and neutralize this phosphorus before it can enter the bloodstream.

  • Mechanism 1 (The Phosphate Trap): When taken with meals, Calcium Acetate reacts with dietary phosphorus to form Insoluble Calcium Phosphate. Because this compound is a large, solid precipitate, it cannot be absorbed by the intestines and is safely excreted through the feces.

  • Mechanism 2 (High Binding Affinity): Calcium Acetate is chemically superior to Calcium Carbonate for this purpose because it has a significantly higher binding affinity for phosphate at the neutral pH found in the small intestine. This means it traps more phosphorus with less elemental calcium absorption.

  • Mechanism 3 (Prevention of Calcification): By maintaining “Phosphate Homeostasis,” the drug prevents Secondary Hyperparathyroidism and the lethal calcification of soft tissues and blood vessels (Calciphylaxis), which is a leading cause of death in dialysis patients.

Technical & Logistics Specifications

  • HS Code: 2915.29.90 (Salts of Acetic Acid – Calcium Acetate)

  • CAS Number: 62-54-4 (Calcium Acetate)

  • Dosage Form: Film-Coated Tablet (Immediate Release)

  • Packaging: Alu-Alu Blisters or HDPE Bottles. Calcium Acetate is hygroscopic; our moisture-lock packaging ensures 36-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

  • Solubility Mastery: We utilize advanced granulation to ensure our tablets match the Acid-Independent Dissolution profile of the innovator brand (e.g., PhosLo), which is critical for patients also taking PPIs or antacids.

  • Elemental Precision: Our facility utilizes Atomic Absorption Spectroscopy (AAS) to guarantee the exact elemental calcium content, ensuring clinicians can accurately calculate the “Calcium-Phosphate Product” for their patients.

Primary Indications

  • Nephrology: Control of Hyperphosphatemia in patients with End-Stage Renal Disease (ESRD) on hemodialysis or peritoneal dialysis.

  • Internal Medicine: Management of phosphorus levels in advanced Chronic Kidney Disease (CKD) stages 3 and 4.

Dosage & Administration

  • Standard Dosing: Usually 2 tablets (1334 mg) taken with each meal. The dose is titrated based on serum phosphorus levels.

  • The “Meal-Time” Mandate (CRITICAL): These tablets MUST be taken with food. If taken on an empty stomach, the drug will not bind dietary phosphorus and will instead cause excessive calcium absorption, leading to hypercalcemia.

Safety Warning: Risk of Hypercalcemia. Monitor serum calcium levels twice weekly during dose titration. Patients should be warned not to take additional calcium supplements or antacids without consulting a nephrologist.

Global Export & Contract Manufacturing

Healthy Inc is a premier Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for specialized Nephrology Therapeutics. Whether you are a Dialysis Network Buyer in Africa or a B2B Pharma Marketplace partner in the CIS, we ensure secure, WHO-GMP compliant delivery.

Add to cart